HRK and colorectal cancer: For instance, harakiri, BCL2 interacting protein (HRK) is downregulated in colorectal cancer tissues and cells, and its below-normal expression promotes apoptosis and inhibits the PI3K/AKT signaling pathway, reducing growth and migration of colorectal cancer cells [19].